DeepDx® Prostate
| Solution Type | AI Suite/Add-on |
|---|---|
| Deployment Environment | Clinical Diagnostics |
| Regulatory Clearance | Prostate Cancer – CE-IVD, Prostate Cancer – South Korea IVD |
| Target | Prostate Cancer |
| Platform Dependency | Requires Specific Platform |
| Deployment Options | Hybrid (Cloud analysis, local viewer) |
Be the first to review “DeepDx® Prostate” Cancel reply
Have you considered:
Compare Solutions
No products to compare
Get Pathology News Delivered to Your Inbox
News
Editor2026-10-07T11:25:13+00:00
Pathology Bites: Tackling NHS Backlogs with Source Bioscience and Indica Labs
Editor2026-10-07T11:25:13+00:00October 7, 2026|
Editor2026-10-06T09:59:05+00:00
Micro Highlight #38 – AI Fluency in Pathology: Understanding the Technology Behind the Tools
Editor2026-10-06T09:59:05+00:00October 6, 2026|
Editor2026-10-06T09:19:24+00:00
EVIDENT Completes Acquisition of CrestOptics S.p.A.
Editor2026-10-06T09:19:24+00:00October 6, 2026|
Editor2026-10-06T09:00:54+00:00
Haga Bioscience and Imagenomix announce collaboration to advance AI-enabled spatial biomarker discovery in oncology
Editor2026-10-06T09:00:54+00:00October 6, 2026|
Editor2026-10-05T10:23:56+00:00
Grundium unveils Ocus R, bringing a new architecture to high-throughput digital pathology
Editor2026-10-05T10:23:56+00:00October 5, 2026|
Editor2026-10-05T09:05:02+00:00
New Spatial GWAS Atlas Maps Disease Variants to Specific Cells and Tissue Regions
Editor2026-10-05T09:05:02+00:00October 5, 2026|
Editor2026-10-05T08:53:58+00:00
PathPresenter co-Founder Dr. Rajendra Singh named to The Pathologist’s Power List 2026
Editor2026-10-05T08:53:58+00:00October 5, 2026|
























Reviews
There are no reviews yet.